Protein

Cytovance to manufacture Pamlico Biopharma antibodies

Cytovance to manufacture Pamlico Biopharma antibodies

By Zachary Brennan

CMO Cytovance Biologics has entered into a manufacturing agreement with Pamlico Biopharma to develop a group of three human IgG monoclonal antibodies intended for the treatment of Streptococcus pneumoniae infections. 

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers